Galectin Therapeutics (GALT) Prepaid Assets (2010 - 2026)

Galectin Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 14.78% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 14.78% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 19.51% from the prior year.
• Prepaid Assets retreated to $1.6 million in Q1 2026 per GALT's latest filing, from $1.7 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $2.1 million in Q4 2024 and bottomed at $1.2 million in Q3 2025.
• The 5-year median for Prepaid Assets is $1.7 million (2024), against an average of $1.7 million.
• Across the five-year window, Prepaid Assets grew 28.58% in 2024 and fell 25.03% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $2.0 million in 2022, then grew by 4.59% to $2.0 million in 2023, then climbed by 4.0% to $2.1 million in 2024, then retreated by 19.51% to $1.7 million in 2025, then dropped by 7.93% to $1.6 million in 2026.
• Per Business Quant, the three latest GALT Prepaid Assets figures stand at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $1.2 million (Q3 2025).